Metlife Stock-Based Compensation Growth & History (MET)

Metlife's stock-based compensation was $131.0M for fiscal 2025.

View full Metlife company overview

Metlife annual stock-based compensation history

Metlife annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$131.0M−$37.0M−22.02%
20242024-12-31$168.0M−$3.0M−1.75%
20232023-12-31$171.0M−$13.0M−7.07%
20222022-12-31$184.0M$11.0M+6.36%
20212021-12-31$173.0M$46.0M+36.22%
20202020-12-31$127.0M−$23.0M−15.33%
20192019-12-31$150.0M$64.0M+74.42%
20182018-12-31$86.0M−$42.0M−32.81%
20172017-12-31$128.0M−$19.0M−12.93%
20162016-12-31$147.0M$10.0M+7.30%
20152015-12-31$137.0M−$55.0M−28.65%
20142014-12-31$192.0M$17.0M+9.71%
20132013-12-31$175.0M$7.0M+4.17%
20122012-12-31$168.0M$24.0M+16.67%
20112011-12-31$144.0M$60.0M+71.43%
20102010-12-31$84.0M$15.0M+21.74%
20092009-12-31$69.0M−$54.0M−43.90%
20082008-12-31$123.0M

Metlife stock-based compensation trends

Over the last five fiscal years, Metlife's stock-based compensation increased from $127.0M to $131.0M, a change of $4.0M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Metlife source filings ↗

Community posts

It’s quiet here.

No posts about MET yet. Start the conversation.

Write the first post